Ticker Details
Arcturus Therapeutics Holdings Inc. Arcturus Therapeutics Ltd is a biotechnology company developing novel RNA medicines. The company develops novel RNA medicines in therapeutic areas including infectious disease, cystic fibrosis, nonalcoholic steatohepatitis (NASH) and rare liver diseases.
IPO Date:	May 22, 2013
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$382.29M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.02 | 4.11%
Avg Daily Range (30 D):	$0.37 | 4.78%
Avg Daily Range (90 D):	$0.28 | 3.61%

Institutional Daily Volume
Avg Daily Volume:	.42M
Avg Daily Volume (30 D):	.72M
Avg Daily Volume (90 D):	.5M

Trade Size
Avg Trade Size (Sh.):	65
Avg Trade Size (Sh.) (30 D):	67
Avg Trade Size (Sh.) (90 D):	58

Institutional Trades
Total Institutional Trades:	2,105
Avg Institutional Trade:	$2.04M
Avg Institutional Trade (30 D):	$1.06M
Avg Institutional Trade (90 D):	$1.16M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.27M
Avg Closing Trade (30 D):	$1.06M
Avg Closing Trade (90 D):	$1.22M
Avg Closing Volume:	79.77K

News

Mar 23, 2026 @ 11:07 AM These Are the Only 3 Stocks That Cathie Wood Bough... Source: Rick Munarriz

Oct 23, 2025 @ 1:15 PM Cathie Wood Goes Shopping: 3 Stocks She Just Bough... Source: Rick Munarriz

Sep 29, 2025 @ 5:35 PM 10 Health Care Stocks With Whale Alerts In Today's... Source: Benzinga Staff Writer

Aug 5, 2025 @ 10:00 AM Lipid Nanoparticles Market Industry Trends, Key Gr... Source: Researchandmarkets.Com

Jul 18, 2025 @ 8:56 AM RNA Therapeutics and RNA Vaccines Market Industry ... Source: Researchandmarkets.Com

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-3.33	$-.84	$-.95
Diluted EPS	$-3.33	$-.84	$-.95
Revenue	$29.37M	$2.96M	$2.06M
Gross Profit
Net Income / Loss	$-93.28M	$-23.79M	$-26.96M
Operating Income / Loss	$-102.3M	$-25.55M	$-28.93M
Cost of Revenue
Net Cash Flow	$-59.84M	$-19.89M	$-19.39M
PE Ratio

Splits
Nov 16, 2017	1:7